File:NLC416-08jh002680-6039 拜耳新藥大全補遺.pdf

Go to page
next page →
next page →
next page →

Original file(891 × 1,200 pixels, file size: 2.09 MB, MIME type: application/pdf, 72 pages)

Captions

Captions

Add a one-line explanation of what this file represents

Summary edit

拜耳新藥大全補遺   (Wikidata search (Cirrus search) Wikidata query (SPARQL)  Create new Wikidata item based on this file)
Author
[拜耳大藥廠編]
image of artwork listed in title parameter on this page
Title
拜耳新藥大全補遺
Publisher
[拜耳大藥廠] ([上海])
Description

介紹該廠生產的藥品30餘種

目錄
各種良藥
培他生'betaxin'
康巴飛樂'campoferron'
芬固爾'fungol'
益利林'iliren'
百浪多息'prontosil'
聖露斯銻波霜'solustibosan'
蘇潑立芬'suprifen'
烏利龍'uleron'
生物製品
「貝靈」化膿菌抗素'antipyogenbehring'
「貝靈」藥特靈化膿菌混合漿苗antipyogenous'yatren'vaccine
「貝靈」氣管枝性肺炎菌bronchopneumoniavaccine'behring'
「貝靈」流行性感冒菌pneumococcusvaccine'behring'
「貝靈」抗加答及肺炎菌influenzamixedvaccine'behring'
混合漿苗auti-catarrhmixodvaccinc'behring'
「貝靈」白喉預防素(蟻酸醛解毒後之白喉毒素)diphtheria-prophylacticalf.t.'behring'
奧佛拉明'euflamin'
「貝靈」腹膜炎血清anti-peritonitisserum'behring'
飛散特靈'physantrin'
用藥表
子宮附屬器官病
奧佛拉明'euflamin'
心臟衰弱虛脫血壓驟降等症
蘇潑立芬'suprifen'
白濁及其各種合併症小兒陰門膣道炎
烏利龍'uleron'
白喉預防
「貝靈」白喉預防素(蟻酸醛解毒後之白喉毒素)diphtheria-prophylacticalf.t.'behring'
百日咳
飛散特靈'physantrin'
各種鋉狀球菌葡萄狀球菌惹成之病症若敗血性喉蛾敗血性猩紅熱敗血性產褥熱等
百浪多息'prontosil'
各種化膿症候葡萄狀球菌鋉狀球菌肺炎菌大腸菌青膿菌惹成之症候
「貝靈」化膿菌抗素'antipyogenbehring'
「貝靈」藥特靈化膿菌混合苗漿antipyogenous'yatren'vaccine
各種續發性貧血身體衰弱病後元虧
康巴飛樂'campoferron'
香港腳(足趾濕癢)
芬固爾'fungol'
肺炎氣管枝性肺炎流行性感冒答兒
「貝靈」氣管枝性肺炎菌bronchopneumoniavaccine'behring'
「貝靈」流行性感冒菌pneumococcusvaccine'behring'
「貝靈」抗加答及肺炎菌influenzamixedvaccine'behring'
混合漿苗anti-catarrhmixcdvaccine'behring'
腳氣病及神經炎
培他生'betaxin'
黑熱病及多發性硬化症
聖露斯銻波霜'solustibosan'
腹膜炎
「貝靈」腹膜炎血清anti-peritonitisserum'behring'
腎臟腺機能消失及體虛軟弱等症
益利林'iliren'

Language Chinese
Publication date [1938]
Source
institution QS:P195,Q732353
(民國時期文獻 民國圖書)
主題
InfoField
藥品
中圖分類
InfoField
R97
拼音題名
InfoField
bai er xin yao da quan bu yi
載體形態
InfoField
65頁

Licensing edit

This image is in the public domain because it is a mere mechanical scan or photocopy of a public domain original, or – from the available evidence – is so similar to such a scan or photocopy that no copyright protection can be expected to arise. The original itself is in the public domain for the following reason:
Public domain
This image is now in the public domain in China because its term of copyright has expired.

According to copyright laws of the People's Republic of China (with legal jurisdiction in the mainland only, excluding Hong Kong and Macao), amended November 11, 2020, Works of legal persons or organizations without legal personality, or service works, or audiovisual works, enter the public domain 50 years after they were first published, or if unpublished 50 years from creation. For photography works of natural persons whose copyright protection period expires before June 1, 2021 belong to the public domain. All other works of natural persons enter the public domain 50 years after the death of the creator.
According to copyright laws of Republic of China (currently with jurisdiction in Taiwan, Penghu, Kinmen, Matsu, etc.), all photographs and cinematographic works, and all works whose copyright holder is a juristic person, enter the public domain 50 years after they were first published, or if unpublished 50 years from creation, and all other applicable works enter the public domain 50 years after the death of the creator.

Important note: Works of foreign (non-U.S.) origin must be out of copyright or freely licensed in both their home country and the United States in order to be accepted on Commons. Works of Chinese origin that have entered the public domain in the U.S. due to certain circumstances (such as publication in noncompliance with U.S. copyright formalities) may have had their U.S. copyright restored under the Uruguay Round Agreements Act (URAA) if the work was under copyright in its country of origin on the date that the URAA took effect in that country. (For the People's Republic of China, the URAA took effect on January 1, 1996. For the Republic of China (ROC), the URAA took effect on January 1, 2002.[1])
To uploader: Please provide where the image was first published and who created it or held its copyright.

You must also include a United States public domain tag to indicate why this work is in the public domain in the United States. Note that this work might not be in the public domain in countries that do not apply the rule of the shorter term and have copyright terms longer than life of the author plus 50 years. In particular, Mexico is 100 years, Jamaica is 95 years, Colombia is 80 years, Guatemala and Samoa are 75 years, Switzerland and the United States are 70 years, and Venezuela is 60 years.


čeština  Deutsch  English  português  română  slovenščina  Tagalog  Tiếng Việt  македонски  русский  മലയാളം  ไทย  한국어  日本語  简体中文‎  繁體中文  +/−



This tag is designed for use where there may be a need to assert that any enhancements (eg brightness, contrast, colour-matching, sharpening) are in themselves insufficiently creative to generate a new copyright. It can be used where it is unknown whether any enhancements have been made, as well as when the enhancements are clear but insufficient. For known raw unenhanced scans you can use an appropriate {{PD-old}} tag instead. For usage, see Commons:When to use the PD-scan tag.


Note: This tag applies to scans and photocopies only. For photographs of public domain originals taken from afar, {{PD-Art}} may be applicable. See Commons:When to use the PD-Art tag.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current14:06, 21 April 2023Thumbnail for version as of 14:06, 21 April 2023891 × 1,200, 72 pages (2.09 MB)PencakeBot (talk | contribs)Upload 拜耳新藥大全補遺 (1/1) by [拜耳大藥廠編] (batch task; nlc:data_416,08jh002680,6039; 民國圖書-PD2022.2; 拜耳新藥大全補遺)

Metadata